Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio viaAIB1 or SMRT recruitment to the CCND1 and MYC promoters

Publisher： John Wiley & Sons Inc

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.136, Iss.11, 2015-06, pp. : 2680-2692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of AIB1 for Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells

By  

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 159-168

Karger

Access to resources Recommend Favorite

Clinicopathological features of double‐hit B‐cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 10, 2015-10 ,pp. : 519-527

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coexistence of Copy Number Increases of c-Myc, ZNF217, CCND1, ErbB1 and ErbB2 in Ovarian Cancers

By  

Oncology Research and Treatment, Vol. 32, Iss. 7, 2009-06 ,pp. : 405-410

Karger

Access to resources Recommend Favorite

MYC and MXI1 Protein Expression: Potential Prognostic Significance in Women with Breast Cancer in China

By  

Oncology Research and Treatment, Vol. 37, Iss. 3, 2014-02 ,pp. : 118-123

Karger

Access to resources Recommend Favorite

Progestin and breast cancer: The missing pieces of a puzzle

By Giersig Cecylia  

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, Vol. 51, Iss. 8, 2008-08 ,pp. : 946-946

Springer Publishing Company

Access to resources Recommend Favorite